Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios Revenue (Quarterly): 3.195M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.195M |
| March 31, 2024 | 0.0674M |
| December 31, 2023 | 0.0474M |
| September 30, 2023 | 0.0485M |
| June 30, 2023 | 0.7288M |
| March 31, 2023 | 0.053M |
| December 31, 2022 | 0.4256M |
| September 30, 2022 | 0.0579M |
| June 30, 2022 | 0.0849M |
| March 31, 2022 | 0.0947M |
| December 31, 2021 | 0.0968M |
| September 30, 2021 | 0.0999M |
| June 30, 2021 | 0.0914M |
| March 31, 2021 | 0.085M |
| December 31, 2020 | 0.0574M |
| September 30, 2020 | 0.066M |
| June 30, 2020 | 0.065M |
| March 31, 2020 | 0.0643M |
| December 31, 2019 | 0.0644M |
| Date | Value |
|---|---|
| September 30, 2019 | 0.0653M |
| June 30, 2019 | -0.3093M |
| March 31, 2019 | 0.9898M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 0.063M |
| March 31, 2017 | 0.1759M |
| December 31, 2016 | 0.1826M |
| September 30, 2016 | 0.1548M |
| June 30, 2016 | 0.1963M |
| March 31, 2016 | 0.1793M |
| December 31, 2015 | 0.1797M |
| September 30, 2015 | 0.1408M |
| June 30, 2015 | 0.3235M |
| March 31, 2015 | 0.1669M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0474M
Minimum
Dec 2023
3.195M
Maximum
Jun 2024
0.2891M
Average
0.0674M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.918B |
| Nxera Pharma Co Ltd | 62.36M |
| PeptiDream Inc | 204.69M |
| AnGes Inc | 0.8352M |
| SanBio Co Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.426M |
| Total Expenses (Quarterly) | 5.004M |
| EPS Diluted (Quarterly) | -0.038 |
| Enterprise Value | 117.61M |
| Gross Profit Margin (Quarterly) | 86.35% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -31.22% |
| Normalized Earnings Yield | -31.22 |